Proximity Co-aggregation Protein Interaction Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack efficient, system-wide monitoring and hypothesis-free identification of protein-protein interactions and protein complexes directly in cells and tissues, which is crucial for understanding dynamic interactions and their modulation in diseases.

Innovation Solution

A method involving exposing protein samples to preselected conditions, isolating soluble and insoluble fractions, and analyzing them to identify protein interactions using proximity co-aggregation (PCA) signatures, which correlates with interaction stoichiometry and abundance, allowing for the monitoring of protein complex dynamics.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If current methods are used to study protein interactions, then some protein interactions can be identified, but efficient system-wide monitoring and hypothesis-free identification directly in cells and tissues cannot be achieved

Engineering Contradiction:
Improvesystem-wide monitoring efficiencyVSAvoidmethod complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The method segments the complex problem of protein interaction detection into manageable components: (1) exposing samples to controlled conditions, (2) separating soluble and insoluble fractions, and (3) analyzing fractions to identify interactions. This segmentation enables systematic study while maintaining methodological clarity and reducing overall complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The method employs universal procedures that can be applied across different cell types, physiological states, and disease conditions without requiring method modification. The standardized workflow of condition exposure, fraction separation, and interaction analysis provides a multi-functional approach that works hypothesis-free across diverse biological systems.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If protein samples are exposed to multiple conditions for extended durations, then interaction identification accuracy improves, but sample degradation and loss of information increase

Engineering Contradiction:
Improveinteraction identification accuracyVSAvoidsample degradation
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The method performs preliminary fraction separation before conducting interaction analysis. By separating soluble and insoluble fractions in advance, the system preserves sample integrity and prevents degradation that would occur during extended analysis procedures. This preliminary action enables accurate interaction identification while minimizing sample loss.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The method uses rapid condition exposure and quick fraction separation to minimize the time samples are subjected to potentially degrading conditions. By rushing through the critical separation step efficiently, the system achieves high measurement precision without allowing significant sample degradation to occur.

Inventive Principle:
Principle #21Skipping (Rushing through)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the systematic study and monitoring of protein interactions and complexes, facilitating the identification of therapeutic targets, disease progression prognosis, and understanding protein function and pathways, with high reproducibility across different cellular conditions.

Implementation Method 1

analyzing them to identify protein interactions using proximity co-aggregation (PCA) signatures

Methodology Applied
Scientific EffectProximity co-aggregation: Coagulation

Data Source

PatentUS11630110B2Methods to identify protein interaction
Publication Date: 2023.04.18 AGENCY FOR SCI TECH & RES
  • US11630110B2 patent drawing
  • US11630110B2 patent drawing
  • US11630110B2 patent drawing

AI summary

The present invention discloses methods for identifying a protein interaction between one or more first proteins and one or more further proteins comprising the steps of: exposing one or more samples comprising the proteins to at least one preselected condition for at least one preselected duration; isolating and separating at least one soluble fraction from an insoluble fraction of said one or more samples; and analyzing the at least one soluble fraction or the insoluble fraction to identify said protein interaction between one or more first proteins and one or more further proteins. Use of the method of the invention are also disclosed.